STOCK TITAN

Stryker Corporation - SYK STOCK NEWS

Welcome to our dedicated page for Stryker Corporation news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker Corporation stock.

Stryker Corporation, based in Kalamazoo, Michigan, is an American multinational renowned for its groundbreaking medical technologies. The company designs, manufactures, and markets a wide array of medical equipment and devices that play critical roles in healthcare settings around the globe.

Stryker's comprehensive product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds, gurneys, and spinal devices. The company is a dominant force in the medical sector, holding a top-three position in reconstructive orthopedic implants and leading in operating room equipment.

In the most recent financial updates, Stryker reported impressive operating results for the fourth quarter and the full year of 2023. With organic sales growth exceeding 11% and surpassing $20 billion in sales, the company has shown robust performance. Kevin Lobo, Chair and CEO, attributes this success to the dedicated teams driving high growth and strong adjusted earnings.

Stryker's influence extends globally, impacting over 150 million patients annually through its work in MedSurg, Neurotechnology, Orthopaedics, and Spine. Just over a quarter of its total revenue is generated from markets outside the United States, highlighting its international presence and reach.

The company continues to innovate and expand its horizons. For instance, Stryker will disclose its financial results for the first quarter of fiscal year 2024 on April 30, 2024. This forthcoming report is anticipated to provide further insights into the company’s financial health and ongoing projects.

For those interested in staying updated, Stryker's press releases and financial disclosures are readily available on their website. The corporation maintains a strong commitment to improving healthcare outcomes and enhancing patient care through its innovative products and services.

News
Rhea-AI Summary
Stryker to host Investor Day on November 8, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
conferences
-
Rhea-AI Summary
Stryker will report financial results for Q3 FY2023 on Nov 2, 2023. A press release will include summary financial information for the quarter. A webcast will be held to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
-
Rhea-AI Summary
Stryker celebrates 10th anniversary of Triathlon Tritanium baseplate with over 1 million knees implanted globally
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
none
Rhea-AI Summary
Stryker launches PROstep MIS Lapidus, a new internal fixation system for treating bunions using minimally invasive surgery
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
none
-
Rhea-AI Summary
Stryker unveils next-generation surgical camera platform with enhanced imaging capabilities
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
none
-
Rhea-AI Summary
Stryker's Pangea Systems receive FDA clearance, offering surgeons a comprehensive portfolio for trauma needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
conferences
-
Rhea-AI Summary
SYK: Stryker Launches 'Scan. Plan. Mako Can.' Campaign to Promote Mako SmartRobotics™ for Joint Replacement Surgery
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
-
Rhea-AI Summary
Stryker reports strong Q2 2023 results with net sales increasing 11.2% to $5.0 billion. Organic net sales also increased by 11.9%. Adjusted operating income margin increased by 60 bps to 24.3%. The company expects full-year organic net sales growth to be in the range of 9.5% to 10.5%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
Rhea-AI Summary
Stryker (NYSE:SYK) has announced a 7.9% increase in its quarterly dividend to $0.75 per share, payable on October 31, 2023. The company is a leading medical technology firm, offering innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine, impacting over 130 million patients annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
dividends

FAQ

What is the current stock price of Stryker Corporation (SYK)?

The current stock price of Stryker Corporation (SYK) is $364.1 as of January 9, 2025.

What is the market cap of Stryker Corporation (SYK)?

The market cap of Stryker Corporation (SYK) is approximately 138.8B.

What does Stryker Corporation specialize in?

Stryker Corporation specializes in designing, manufacturing, and marketing medical equipment and devices, including orthopedic implants, endoscopy systems, and operating room equipment.

Where is Stryker Corporation headquartered?

Stryker Corporation is headquartered in Kalamazoo, Michigan, USA.

How did Stryker perform financially in 2023?

Stryker reported excellent organic sales growth of over 11% for both the fourth quarter and the full year of 2023, surpassing $20 billion in sales.

What is the scope of Stryker's global impact?

Stryker impacts over 150 million patients annually and generates just over a quarter of its total revenue from outside the United States.

What are some of the products offered by Stryker?

Stryker's products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds, gurneys, and spinal devices.

When will Stryker report its financial results for Q1 2024?

Stryker will report its financial results for the first quarter of fiscal year 2024 on April 30, 2024.

How can I access Stryker's financial reports?

Stryker's financial reports and press releases can be accessed on their website under the Press Releases and Events & Presentations sections.

Who should I contact for investor inquiries at Stryker?

For investor inquiries, contact Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com.

What areas does Stryker focus its innovations on?

Stryker focuses its innovations on MedSurg, Neurotechnology, Orthopaedics, and Spine to improve patient and healthcare outcomes.

How can I stay updated with Stryker's latest developments?

You can stay updated with Stryker's latest developments by following their press releases and financial disclosures available on their website.
Stryker Corporation

NYSE:SYK

SYK Rankings

SYK Stock Data

138.80B
360.31M
5.38%
80.47%
1.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
PORTAGE